H.C. Wainwright Lifts PT on Innoviva (INVA) to $46 From $45, Keeps a Buy Rating

Innoviva, Inc. (NASDAQ:INVA) is one of the best small cap stocks to buy with huge upside potential. Innoviva, Inc. (NASDAQ:INVA) received a rating update from H.C. Wainwright on December 16, who lifted the price target to $46 from$ 45 while keeping a Buy rating on the stock. Innoviva, Inc. (INVA): Among Stocks with Insanely High PE Ratios Insiders Are Selling The rating update came after Innoviva, Inc. (NASDAQ:INVA) reported the FDA approval of NUZOLVENCE® (zoliflodacin) on December 12, with the firm tel ...